Journal
CURRENT ALLERGY AND ASTHMA REPORTS
Volume 9, Issue 4, Pages 304-310Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11882-009-0043-0
Keywords
-
Categories
Ask authors/readers for more resources
Allergic rhinoconjunctivitis (ARC) is a common allergic condition associated with high financial costs and decreased quality of life. Medical treatment options are extensive and include oral, ophthalmic, and intranasal agents. Intranasal corticosteroids (INS) have traditionally been used for chronic management of nasal symptoms, but have also demonstrated an impact on decreasing ocular symptoms of itching, tearing, and redness. Study design, including the method and timing of scoring ocular symptoms, is an important factor affecting whether changes in ocular symptoms are detected in INS clinical trials. INS are thought to exert their influence on the eye through the naso-ocular reflex, and to date their impact on ocular symptoms appears to be a class effect.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available